Cargando…
High-mix insulins
Premix insulins are commonly used insulin preparations, which are available in varying ratios of different molecules. These drugs contain one short- or rapid-acting, and one intermediate- or long-acting insulin. High-mix insulins are mixtures of insulins that contain 50% or more than 50% of short-ac...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566356/ https://www.ncbi.nlm.nih.gov/pubmed/26425485 http://dx.doi.org/10.4103/2230-8210.163214 |
_version_ | 1782389708927533056 |
---|---|
author | Kalra, Sanjay Farooqi, Mohammad Hamed El-Houni, Ali E. |
author_facet | Kalra, Sanjay Farooqi, Mohammad Hamed El-Houni, Ali E. |
author_sort | Kalra, Sanjay |
collection | PubMed |
description | Premix insulins are commonly used insulin preparations, which are available in varying ratios of different molecules. These drugs contain one short- or rapid-acting, and one intermediate- or long-acting insulin. High-mix insulins are mixtures of insulins that contain 50% or more than 50% of short-acting insulin. This review describes the clinical pharmacology of high-mix insulins, including data from randomized controlled trials. It suggests various ways, in which high-mix insulin can be used, including once daily, twice daily, thrice daily, hetero-mix, and reverse regimes. The authors provide a rational framework to help diabetes care professionals, identify indications for pragmatic high-mix use. |
format | Online Article Text |
id | pubmed-4566356 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-45663562015-09-30 High-mix insulins Kalra, Sanjay Farooqi, Mohammad Hamed El-Houni, Ali E. Indian J Endocrinol Metab Brief Communication Premix insulins are commonly used insulin preparations, which are available in varying ratios of different molecules. These drugs contain one short- or rapid-acting, and one intermediate- or long-acting insulin. High-mix insulins are mixtures of insulins that contain 50% or more than 50% of short-acting insulin. This review describes the clinical pharmacology of high-mix insulins, including data from randomized controlled trials. It suggests various ways, in which high-mix insulin can be used, including once daily, twice daily, thrice daily, hetero-mix, and reverse regimes. The authors provide a rational framework to help diabetes care professionals, identify indications for pragmatic high-mix use. Medknow Publications & Media Pvt Ltd 2015 /pmc/articles/PMC4566356/ /pubmed/26425485 http://dx.doi.org/10.4103/2230-8210.163214 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Kalra, Sanjay Farooqi, Mohammad Hamed El-Houni, Ali E. High-mix insulins |
title | High-mix insulins |
title_full | High-mix insulins |
title_fullStr | High-mix insulins |
title_full_unstemmed | High-mix insulins |
title_short | High-mix insulins |
title_sort | high-mix insulins |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4566356/ https://www.ncbi.nlm.nih.gov/pubmed/26425485 http://dx.doi.org/10.4103/2230-8210.163214 |
work_keys_str_mv | AT kalrasanjay highmixinsulins AT farooqimohammadhamed highmixinsulins AT elhounialie highmixinsulins |